Icon

TEPADINA (nda208264)- (15MG/VIAL,100MG/VIAL)

THIOTEPA ADIENNE SA
15MG/VIAL,100MG/VIAL
No Yes
Expired Expired
2024-Jan-26 None
None No
TEPADINA (thiotepa) is an alkylating drug indicated:  To reduce the risk of graft rejection when used in conjunction with high-dose busulfan and cyclophosphamide as a preparative regimen for allogeneic hematopoietic progenitor (stem) cell transplantation (HSCT) for pediatric patients with class 3 beta-thalassemia.  For treatment of adenocarcinoma of the breast or ovary.  For controlling intracavitary effusions secondary to diffuse or localized neoplastic diseases of various serosal cavities.  For treatment of superficial papillary carcinoma of the urinary bladder.
5 0 4
Total Other Developers 5
Drugs with Suitability No
15MG/VIAL ** ** - - -
100MG/VIAL ** ** - - -
NDA Sales Available Total Generic Sales Available
No 1
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** *** *** ************ ******* ******* *********** ************ ********, ****-**, ****** ***. ****& **** ** ****, ********* (*******), ********* (******), ********** ********, ********* ******, ***** (***) ***
****** ***** ****** *** ***** ****** ******* *********** **** * & **** **, ***** *, ***** *, ************* ******* ******** **** (**** ), *******, *************, ****** ******* ******, ***** (***) ***
****** ******** ****** *************** **., ***. *********** **.*-* ***** ****, ******* **-**** ************* ****** ****, *******, ******* ******, ***** (***) ***
****** ***** ********** **** ********* *********** ************ **, **********, ***** ****** *****, ******* (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.